Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Raltegravir, an HIV-1 integrase inhibitor for HIV infection.
Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients.
Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.
Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.
Naive CD4(+) T cells and recent thymic emigrant levels in treated individuals with HIV: clinical relevance.
[Resistance genotyping in patients with therapeutic failure].
Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide.
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.
Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events.
Anti-HIV activity of a novel aminoglycoside-arginine conjugate.